TI
INBX

Trexquant Investment’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Trexquant Investment’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-18,186
Closed -$343K – 1920
2023
Q1 		$343K Buy
+18,186
New +$423K 0.01% 1147
2022
Q4 		– Sell
-16,912
Closed -$304K – 1864
2022
Q3 		$304K Buy
16,912
+180
+1% +$3.25K 0.01% 1033
2022
Q2 		$190K Buy
+16,732
New +$246K 0.01% 1366

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Trexquant Investment's INBX Position: Q2 2023 in Review

Trexquant Investment sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2023, closing a stake of 18,186 shares — an estimated $343K sold.

Trexquant Investment first reported a position in INBX in Q2 2022 and held it in 3 quarters. The position peaked at $343K in Q1 2023. 107 funds tracked by Wall St. Rank hold INBX as of Q2 2023.

  • Trexquant Investment reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Trexquant Investment sold 18,186 Inhibrx, Inc. Common Stock shares in Q2 2023, an estimated $343K.
  • Trexquant Investment first reported a position in Inhibrx, Inc. Common Stock in Q2 2022 and held it in 3 quarters.
  • Trexquant Investment's Inhibrx, Inc. Common Stock position peaked at $343K in Q1 2023.
  • 107 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2023.

Based on Trexquant Investment's 13F filing for Q2 2023, filed 11 Aug 2023.